Select Publications
Journal articles
2007, 'Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction', Nature Immunology, 8, pp. 1246 - 1254
,2006, 'CD127+CCR5+CD38+++CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells', Journal of Virology, 80, pp. 10151 - 10161
,2006, 'Decimated or missing in action:CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection. Curr HIV/AIDS Rep 2006;3(1):5-12.', Current HIV/AIDS Reports, 3, pp. 5 - 12
,2006, 'Expression of IL-2 and IL-7 receptors discriminates between human regulatory and activated T-cells within CD45RA and CD45RO compartments', Clinical Immunology, 119, pp. S7 - S7
,2006, 'Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells', Journal of Experimental Medicine, 203, pp. 1693 - 1700, http://dx.doi.org/10.1084/jem.20060468
,2006, 'Generation in vitro of T lineage cells from human adult haematopoietic stem cells', Clinical Immunology, 119, pp. S160 - S160
,2006, 'Increased plasma interleukin-7 level correlates with decreased CD127 and increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection', Journal of Infectious Diseases, 193, pp. 505 - 514
,2006, 'Infection of CD127(+) (Interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection', Journal of Virology, 80, pp. 10162 - 10172
,2006, 'T lineage differentiation in vitro of adult Haematopoietic Stem Cells', CYTOMETRY PART A, 69A, pp. 399 - 400
,2006, 'The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostatis and the challenges facing its utilization as a novel therapy. 2006;7:1571-1582.', Current Drug Targets, 7, pp. 1571 - 1582
,2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 42, pp. 192 - 202
,2005, 'A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1', AIDS Research and Human Retroviruses, 21, pp. 395 - 397
,2005, 'CD8(+) T cell dynamics during primary simian immunodeficiency virus infection in macaques: Relationship of effector cell differentiation with the extent of viral replication', Journal of Immunology, 174, pp. 6898 - 6908
,2005, 'Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection', Blood, 106, pp. 1660 - 1667
,2005, 'Impaired mitochondrial function induced by NRTIs is only detectable in the monocyte (CD14(+)) subset of human PBMC', Antiviral Therapy, 10, pp. L44 - L45
,2005, 'Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region.', Journal of RNAi and Gene Silencing, 1, pp. 66 - 78
,2004, 'Increased natural killer cell activity in viremic HIV-1 infection', Journal of Immunology, 173, pp. 5305 - 5311, http://dx.doi.org/10.4049/jimmunol.173.8.5305
,2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection', Blood, 103, pp. 2238 - 2247, http://dx.doi.org/10.1182/blood-2003-08-2765
,2004, 'HIV-1-specific cytotoxicity is preferentially mediated by a subset ofCD8(+) T cells producing both interferon-gamma and tumor necrosisfactor-alpha', Blood, 104, pp. 487 - 494
,2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection', Blood, 8, pp. 2765 - 2765
,2004, 'Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy', Annals of Oncology, 15, pp. 324 - 329
,2003, 'Development of real-time detection direct test for hepatitis B virus and comparison with two commercial tests using the WHO international standard', Journal of Gastroenterology and Hepatology (Australia), 18, pp. 1264 - 1271, http://dx.doi.org/10.1046/j.1440-1746.2003.03204.x
,2003, 'First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection', Virology, 312, pp. 135 - 135
,2003, 'Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine and nelfinavir before complete HIV type 1 seroconversion', AIDS Research and Human Retroviruses, 19, pp. 189 - 199
,2003, 'Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells', Cancer research, 63, pp. 5034 - 5040
,2003, 'Naive T cells maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty', Immunology and Cell Biology, 81, pp. 487 - 495
,2003, 'Polyclonal proliferation and apoptosis of CCR5+ T Lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2', Journal of Infectious Diseases, 187, pp. 1735 - 1735
,2002, 'Structured treatment interruption and beyond', BIOFUTUR, pp. 52 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000180098300009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2002, 'Supervised or structured treatment interruption (STI) and beyond...', Biofutur, pp. 52 - 58
,2002, 'Cell turnover and cell tropism in HIV-1 infection', Trends in Microbiology, 10, pp. 275 - 278
,2002, 'Characterization of CD4(+) CTLs ex vivo', Journal of Immunology, 168, pp. 5954 - 5958
,2002, 'Characterization of the phenotypic and lymphokine profile associated with strong CD8+ anti-HIV-1 suppressor activity (CASA', Clinical and Experimental Immunology, 127, pp. 145 - 150
,2002, 'Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection', Virology, 304, pp. 246 - 264
,2002, 'Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection', Journal of Immunology, 169, pp. 4657 - 4666
,2002, 'Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection', AIDS, 16, pp. 589 - 596
,2002, 'STI and beyond: the prospects of boosting anti-HIV immune responses', Trends in Immunology, 23, pp. 456 - 460
,2002, 'The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy', AIDS, 16, pp. 359 - 367
,2001, 'An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC)', Journal of Clinical Virology, 22, pp. 263 - 270, http://dx.doi.org/10.1016/S1386-6532(01)00198-6
,2001, 'HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism.', The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 15, pp. 5 - 6, http://dx.doi.org/10.1096/fj.00-0336fje
,2001, 'Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine', AIDS Research and Human Retroviruses, 17, pp. 1293 - 1296, http://dx.doi.org/10.1089/088922201750461366
,2001, 'Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs', AIDS Research and Human Retroviruses, 17, pp. 487 - 497
,2001, 'Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.', Journal of Infectious Diseases, 183, pp. 736 - 743
,2001, 'Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modelling.', AIDS Research and Human Retroviruses, 17, pp. 147 - 159
,2000, 'Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes', AIDS Research and Human Retroviruses, 15, pp. 1519 - 1527
,2000, 'Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy', AIDS, 14, pp. 959 - 969
,2000, 'Questions about results reported with potent antiretroviral therapy for human immunodeficiency virus type 1 infection. (Authors¿ reply)', Journal of Infectious Diseases, 181, pp. 1519 - 1520
,2000, 'Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection', AIDS, 14, pp. 2543 - 2551
,1999, 'CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia', Journal of Infectious Diseases, 180, pp. 68 - 75
,1999, 'Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy', Sexually Transmitted Infections, pp. 218 - 224
,1999, 'Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection', Journal of acquired immune deficiency syndrome and human retrovirology, pp. 437 - 444
,